The experimental use and Bolar-type exemptions to patent infringement

Produced in partnership with Charlie French of Bristows and Milly Wickson of Bristows
Practice notes

The experimental use and Bolar-type exemptions to patent infringement

Produced in partnership with Charlie French of Bristows and Milly Wickson of Bristows

Practice notes
imgtext

patent systems are intended to foster innovation, not to impede it. For this reason, the patent laws of many jurisdictions contain exemptions to infringement for experimental use of patented inventions.

This Practice Note examines the two principal research exemptions to patent infringement available under UK law, namely, the general experimental use exemption and the specific ‘Bolar-type’ exemption, including how they have developed in recent years and how they may continue to do so in the future. It also discusses the supplementary protection certificate (SPC) manufacturing waiver which provides an exception to infringement of SPCs (SPCs extend the patent protection for certain medicinal products).

Following Brexit, the body of EU-derived laws has been preserved and converted into UK domestic law with effect on IP completion day (11 pm on 31 December 2020). Relevant Assimilated EU law and Brexit SIs are discussed in the Bolar-type exemption and SPC manufacturing waiver sections below.

Assimilated law is the name given to retained EU law (‘REUL’) which remains

Charlie French
Charlie French

Solicitor, Senior Associate, Bristows


Charlie specialises in contentious intellectual property matters. She has a particular interest in patent litigation in the pharmaceutical and biotechnology sectors, where her background in biochemistry gives her an excellent understanding of the technical issues that arise. She has also advised on the enforcement of plant variety rights, including customs seizures.
 
Charlie has extensive experience representing clients in complex litigation before the Patents Court (High Court) and Court of Appeal, as well as assisting parties in relation to arbitral disputes. She also works closely with lawyers, patent attorneys and regulatory advisors in multiple jurisdictions to coordinate global patent litigation strategies and life-cycle management for pharmaceutical and biotechnology products.
 
Within the life sciences sector, Charlie has advised on disputes relating to small molecule pharmaceuticals, antibodies and antibody engineering technology, gene cloning and cell-based expression systems, drug delivery systems, formulations and dosage regimens. Charlie has also assisted clients in relation to disputes in the fields of shipping, software development and agriculture.

Milly Wickson
Milly Wickson

Solicitor, Bristows


Milly joined Bristows as a trainee solicitor in August 2019. She completed training in September 2021 and qualified into the patent litigation team.
 
Milly has experience working across both the life sciences and technology sectors. Recent work includes UK litigation of telecommunications patents, supporting oppositions at the European Patent Office and giving freedom to operate advice. 
 
During her training, Milly also worked in the brands, designs and copyright team, and was involved in UK trade mark litigation. Milly also has commercial experience and spent three months on secondment to a leading pharmaceuticals company.

Powered by Lexis+®
Jurisdiction(s):
United Kingdom
Key definition:
Patent definition
What does Patent mean?

Patents protect inventions. A grant of patent runs for a term of 20 years provided the periodic renewal fees are paid. Patents are granted by the UK intellectual property Office (UK ipo) for which the inventor or legal owner of the invention can apply.

Popular documents